Longitude Venture Partners II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RAPID MICRO BIOSYSTEMS, INC., Tricida, Inc., Vaxcyte, Inc., Kala Pharmaceuticals, Inc., Venus Concept Inc., Aptinyx Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Longitude Venture Partners II, L.P.'s CIK is 0001527510